Vital Signsby BridgeheadAll voices

01  Voice · Sector leader · Diabetes

Aaron J. Kowalski: no photograph is held, so the sector leader plate is shown instead.
Sector leader

Aaron J. Kowalski

Ph.D., Breakthrough T1D CEO

Press citations per month · linked articles
0
0
0
0
0
0
1
0
0
0
0
0
Dec 2025Jan 2026FebMarAprMayJuneJulyAugSeptOctNovto date
2

press citations on 1 topic since 16 Oct 2025 · last quoted 15 Jun 2026

02  Quoted on · 1 of 29 topics

Open the topic

Aaron J. Kowalski: key facts

Kind of voice
Sector leader
Role
Ph.D., Breakthrough T1D CEO
Quoted on
Diabetes
Tracked press citations
2
Most recently quoted
15 Jun 2026
First quoted
16 Oct 2025

04  On the record · press

What Aaron J. Kowalski has said

By outlet · linked articles
  • breakthrought1d.org1
  • fiercepharma.com1

Where Aaron J. Kowalski has been quoted

  1. 01Sanofi, once on FDA course for speedy approval, gains late expansion for Tzieldfiercepharma.com · 15 Jun 2026
  2. 02Civica long-acting insulin available on January 1, 2026breakthrought1d.org · 16 Oct 2025

Verbatim

“We now have a novel therapy that targets the autoimmune and progressive nature of stage 3 type 1 diabetes.”
Ph.D., CEO of Breakthrough T1D · Diabetes · fiercepharma.com · 15 Jun 2026 · Read the article
“For people with type 1 diabetes, insulin is a lifesaving drug. Too often, the cost of insulin is a barrier that causes people to make difficult decisions between their medication and other necessities. The availability of Civica's insulin glargine is a significant next step in ensuring that insulin is accessible and affordable for people with type 1 diabetes and all those who need it, regardless of their insurance status.”
Ph.D., Breakthrough T1D CEO · Diabetes · breakthrought1d.org · 16 Oct 2025 · Read the article

Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 13 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.